Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

NCT00291577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Sunitinib (Sutent)
DRUG: Taxotere

Sponsor

Pfizer